Article
ABO-compatible liver allograft antibody-mediated rejection: an update.
Current opinion in organ transplantation - 1 Jun 2015
Demetris Anthony J, Zeevi Adriana, O'Leary Jacqueline G
Abstract excerpt
PURPOSE OF REVIEW: Liver allograft antibody-mediated rejection (AMR) studies have lagged behind parallel efforts in kidney and heart because of a comparative inherent hepatic resistance to AMR. Three developments, however, have increased interest: first, solid phase antibody testing enabled more precise antibody characterization; second, increased expectations for long-term, morbidity-free survival; and third,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
